ARVN
Arvinas Inc
NASDAQ: ARVN · HEALTHCARE · BIOTECHNOLOGY
$9.90
+0.81% today
Updated 2026-04-30
Market cap
$667.75M
P/E ratio
—
P/S ratio
2.54x
EPS (TTM)
$-1.14
Dividend yield
—
52W range
$6 – $15
Volume
0.9M
Arvinas Inc (ARVN) Insider transactions
Net insider activity
Net buying (3,005,241 shares)
Buy transactions
74
Sell transactions
26
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-18 | BERKOWITZ, NOAH | Chief Medical Officer | Sale | 6,435 | $11.10 | $71431.07 |
| 2026-03-06 | MORRISON, BRIGGS | Director | Buy | 20,000 | $13.40 | $268070.00 |
| 2026-02-27 | HOUSTON, JOHN G | Director | Sale | 18,822 | $13.24 | $249203.28 |
| 2026-02-27 | HOUSTON, JOHN G | Director | Sale | 11,787 | $13.14 | $154881.18 |
| 2026-02-27 | HOUSTON, JOHN G | Director | Sale | 4,688 | $13.24 | $62069.12 |
| 2026-02-26 | TEEL, RANDY | Director, President and CEO | Buy | 218,691 | — | — |
| 2026-02-26 | TEEL, RANDY | Director, President and CEO | Buy | 147,791 | — | — |
| 2026-02-26 | TEEL, RANDY | Director, President and CEO | Buy | 147,179 | — | — |
| 2026-02-26 | SAIK, ANDREW | Chief Financial Officer | Buy | 67,000 | — | — |
| 2026-02-26 | SAIK, ANDREW | Chief Financial Officer | Buy | 45,000 | — | — |
| 2026-02-26 | LOOMIS, DAVID K | VP, Chief Accounting Officer | Buy | 18,504 | — | — |
| 2026-02-26 | LOOMIS, DAVID K | VP, Chief Accounting Officer | Buy | 12,420 | — | — |
| 2026-02-26 | CACACE, ANGELA M | Chief Scientific Officer | Buy | 67,000 | — | — |
| 2026-02-26 | CACACE, ANGELA M | Chief Scientific Officer | Buy | 45,000 | — | — |
| 2026-02-26 | BERKOWITZ, NOAH | Chief Medical Officer | Buy | 67,000 | — | — |
| 2026-02-26 | BERKOWITZ, NOAH | Chief Medical Officer | Buy | 45,000 | — | — |
| 2026-02-23 | TEEL, RANDY | Director, President and CEO | Sale | 3,748 | $12.16 | $45575.68 |
| 2026-02-23 | TEEL, RANDY | Director, President and CEO | Sale | 1,038 | $12.16 | $12622.08 |
| 2026-02-23 | LOOMIS, DAVID K | Chief Accounting Officer | Sale | 1,108 | $12.16 | $13473.28 |
| 2026-02-23 | CACACE, ANGELA M | Chief Scientific Officer | Sale | 2,571 | $12.16 | $31263.36 |
| 2026-02-23 | CACACE, ANGELA M | Chief Scientific Officer | Sale | 1,038 | $12.16 | $12622.08 |
| 2026-02-13 | TEEL, RANDY | Director, President and CEO | Sale | 4,403 | $11.89 | $52351.67 |
| 2026-02-13 | SAIK, ANDREW | Chief Financial Officer | Sale | 5,134 | $11.89 | $61043.26 |
| 2026-02-13 | LOOMIS, DAVID K | Chief Accounting Officer | Sale | 1,016 | $11.89 | $12080.24 |
| 2026-02-13 | CACACE, ANGELA M | Chief Scientific Officer | Sale | 4,592 | $11.89 | $54598.88 |
| 2026-02-13 | BERKOWITZ, NOAH | Chief Medical Officer | Sale | 5,685 | $11.89 | $67594.65 |
| 2025-11-07 | LOOMIS, DAVID K | Chief Accounting Officer | Sale | 230 | $9.89 | $2274.70 |
| 2025-09-22 | MORRISON, BRIGGS | Director | Buy | 30,000 | $7.57 | $227010.00 |
| 2025-06-25 | YOUNG, JOHN D | Director | Buy | 23,105 | — | — |
| 2025-06-25 | YOUNG, JOHN D | Director | Buy | 16,025 | — | — |
| 2025-06-25 | SMALDONE, ALSUP LAURIE | Director | Buy | 23,105 | — | — |
| 2025-06-25 | SMALDONE, ALSUP LAURIE | Director | Buy | 16,025 | — | — |
| 2025-06-25 | NORWALK, LESLIE V | Director | Buy | 23,105 | — | — |
| 2025-06-25 | NORWALK, LESLIE V | Director | Buy | 16,025 | — | — |
| 2025-06-25 | MORRISON, BRIGGS | Director | Buy | 23,105 | — | — |
| 2025-06-25 | MORRISON, BRIGGS | Director | Buy | 16,025 | — | — |
| 2025-06-25 | KENNEDY, EDWARD MOORE JR. | Director | Buy | 23,105 | — | — |
| 2025-06-25 | KENNEDY, EDWARD MOORE JR. | Director | Buy | 16,025 | — | — |
| 2025-06-25 | CUNNINGHAM, EVERETT | Director | Buy | 23,105 | — | — |
| 2025-06-25 | CUNNINGHAM, EVERETT | Director | Buy | 16,025 | — | — |
| 2025-06-25 | BAIN, LINDA | Director | Buy | 23,105 | — | — |
| 2025-06-25 | BAIN, LINDA | Director | Buy | 16,025 | — | — |
| 2025-06-25 | AGARWAL, SUNIL | Director | Buy | 23,105 | — | — |
| 2025-06-25 | AGARWAL, SUNIL | Director | Buy | 16,025 | — | — |
| 2025-06-24 | SAIK, ANDREW | Chief Financial Officer | Sale | 5,700 | $7.61 | $43377.00 |
| 2025-06-17 | CACACE, ANGELA M | Chief Scientific Officer | Sale | 2,583 | $7.49 | $19346.67 |
| 2025-05-09 | SAIK, ANDREW | Chief Financial Officer | Buy | 91,000 | — | — |
| 2025-05-09 | SAIK, ANDREW | Chief Financial Officer | Buy | 59,600 | — | — |
| 2025-05-09 | LOOMIS, DAVID K | Chief Accounting Officer | Buy | 18,100 | — | — |
| 2025-05-09 | LOOMIS, DAVID K | Chief Accounting Officer | Buy | 11,825 | — | — |
| 2025-05-09 | CACACE, ANGELA M | Chief Scientific Officer | Buy | 91,000 | — | — |
| 2025-05-09 | CACACE, ANGELA M | Chief Scientific Officer | Buy | 59,600 | — | — |
| 2025-05-09 | BERKOWITZ, NOAH | Chief Medical Officer | Buy | 91,000 | — | — |
| 2025-05-09 | BERKOWITZ, NOAH | Chief Medical Officer | Buy | 59,600 | — | — |
| 2025-03-18 | BERKOWITZ, NOAH | Chief Medical Officer | Sale | 8,658 | $8.59 | $74372.22 |
| 2025-02-24 | TAYLOR, IAN | President, R&D | Sale | 7,356 | $16.75 | $123213.00 |
| 2025-02-24 | TAYLOR, IAN | President, R&D | Sale | 1,664 | $16.55 | $27539.20 |
| 2025-02-24 | LOOMIS, DAVID K | Chief Accounting Officer | Sale | 1,214 | $16.75 | $20334.50 |
| 2025-02-24 | HOUSTON, JOHN G | Director, President and CEO | Sale | 26,184 | $16.75 | $438582.00 |
| 2025-02-24 | HOUSTON, JOHN G | Director, President and CEO | Sale | 5,154 | $16.55 | $85298.70 |
| 2025-02-24 | CACACE, ANGELA M | Chief Scientific Officer | Sale | 3,061 | $16.75 | $51271.75 |
| 2025-02-24 | CACACE, ANGELA M | Chief Scientific Officer | Sale | 1,146 | $16.55 | $18966.30 |
| 2025-02-13 | TAYLOR, IAN | Chief Scientific Officer | Buy | 31,483 | — | — |
| 2025-02-13 | TAYLOR, IAN | Chief Scientific Officer | Buy | 20,619 | — | — |
| 2025-02-13 | SAIK, ANDREW | Chief Financial Officer | Buy | 74,960 | — | — |
| 2025-02-13 | SAIK, ANDREW | Chief Financial Officer | Buy | 49,092 | — | — |
| 2025-02-13 | LOOMIS, DAVID K | Chief Accounting Officer | Buy | 16,176 | — | — |
| 2025-02-13 | LOOMIS, DAVID K | Chief Accounting Officer | Buy | 10,584 | — | — |
| 2025-02-13 | HOUSTON, JOHN G | Director, President and CEO | Buy | 232,000 | — | — |
| 2025-02-13 | HOUSTON, JOHN G | Director, President and CEO | Buy | 152,000 | — | — |
| 2025-02-13 | CACACE, ANGELA M | Chief Scientific Officer | Buy | 74,960 | — | — |
| 2025-02-13 | CACACE, ANGELA M | Chief Scientific Officer | Buy | 49,092 | — | — |
| 2025-02-13 | BERKOWITZ, NOAH | Chief Medical Officer | Buy | 84,330 | — | — |
| 2025-02-13 | BERKOWITZ, NOAH | Chief Medical Officer | Buy | 55,229 | — | — |
| 2024-11-07 | LOOMIS, DAVID K | Chief Accounting Officer | Sale | 231 | $27.69 | $6396.39 |
| 2024-06-24 | SAIK, ANDREW | Chief Financial Officer | Buy | 94,418 | — | — |
| 2024-06-24 | SAIK, ANDREW | Chief Financial Officer | Buy | 61,409 | — | — |
| 2024-06-17 | CACACE, ANGELA M | Chief Scientific Officer | Buy | 24,632 | — | — |
| 2024-06-17 | CACACE, ANGELA M | Chief Scientific Officer | Buy | 15,995 | — | — |
| 2024-05-29 | YOUNG, JOHN D | Director | Buy | 9,070 | — | — |
| 2024-05-29 | YOUNG, JOHN D | Director | Buy | 5,899 | — | — |
| 2024-05-29 | SMALDONE, ALSUP LAURIE | Director | Buy | 9,070 | — | — |
| 2024-05-29 | SMALDONE, ALSUP LAURIE | Director | Buy | 5,899 | — | — |
| 2024-05-29 | NORWALK, LESLIE V | Director | Buy | 9,070 | — | — |
| 2024-05-29 | NORWALK, LESLIE V | Director | Buy | 5,899 | — | — |
| 2024-05-29 | MORRISON, BRIGGS | Director | Buy | 9,070 | — | — |
| 2024-05-29 | MORRISON, BRIGGS | Director | Buy | 5,899 | — | — |
| 2024-05-29 | KENNEDY, EDWARD MOORE JR. | Director | Buy | 9,070 | — | — |
| 2024-05-29 | KENNEDY, EDWARD MOORE JR. | Director | Buy | 5,899 | — | — |
| 2024-05-29 | CUNNINGHAM, EVERETT | Director | Buy | 9,070 | — | — |
| 2024-05-29 | CUNNINGHAM, EVERETT | Director | Buy | 5,899 | — | — |
| 2024-05-29 | BAIN, LINDA | Director | Buy | 9,070 | — | — |
| 2024-05-29 | BAIN, LINDA | Director | Buy | 5,899 | — | — |
| 2024-05-29 | AGARWAL, SUNIL | Director | Buy | 9,070 | — | — |
| 2024-05-29 | AGARWAL, SUNIL | Director | Buy | 5,899 | — | — |
| 2024-05-21 | TEEL, RANDY | Int. Chief Financial Officer | Buy | 19,675 | — | — |
| 2024-05-21 | TEEL, RANDY | Int. Chief Financial Officer | Buy | 13,300 | — | — |
| 2024-03-18 | BERKOWITZ, NOAH | Chief Medical Officer | Buy | 93,879 | — | — |
| 2024-03-18 | BERKOWITZ, NOAH | Chief Medical Officer | Buy | 63,452 | — | — |
| 2024-02-23 | TAYLOR, IAN | Chief Scientific Officer | Buy | 58,100 | — | — |